A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects

NCT06762600 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
102
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.